ARTICLE | Company News
Cellectis sales and marketing update
May 28, 2012 7:00 AM UTC
Cellectis' Cellectis stem cells business unit launched hips-HEP. The hepatocyte-like cells are derived from human induced pluripotent stem (iPS) cells and used for in vitro drug discovery, toxicity te...